Evaluation of the effects of noninvasive ventilation on blood gas and depression levels of patients with obesity hypoventilation syndrome


1 Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Psychiatry, Social Security Organization, Shariati Hospital; School of Medicine, Najafabad Azad University, Isfahan, Iran

3 University of Social Welfare and Rehabilitation Sciences, Tehran, Iran


Background: Obesity hypoventilation syndrome (OHS) is associated with increased mechanical load on respiratory system. Here, we aimed to investigate and evaluate the effects of noninvasive ventilation (NIV) on physical and mental status of patients with OHS.
Materials and Methods: The current study is an observational study that was performed in 2020 on 50 patients with OHS in Isfahan, Iran. Beck's Depression Inventory (BDI-II) and Hospital Anxiety and Depression Scale (HADS) questionnaires were also filled for all patients assessing their depression levels that were confirmed by psychiatrists. PO2 and PCO2 of patients were evaluated using venous blood gas (VBG) before interventions. Patients with a definite diagnosis of OHS and depression entered the study and underwent treatments with NIV. One month after the interventions with NIV, the blood gases of patients were evaluated using VBG and BDI-II, and HADS questionnaires were also filled for all patients, evaluating their depression.
Results: The mean age of the subjects was 63.5 ± 13.5. The mean blood oxygen after the use of NIV in patients with OHS increased significantly (P = 0.001). The mean of carbon dioxide after using NIV in patients with OHS decreased significantly (P = 0.001). Based on the BDI-II and HADS scales, the mean score of depression after using NIV decreased significantly (P = 0.001 for both).
Conclusion: NIV therapies are associated with improvements in blood oxygen and CO2 of patients with OHS. The levels of depression also decreased after treatments that were confirmed by psychiatrists.


McNicholas WT, Hansson D, Schiza S, Grote L. Sleep in chronic respiratory disease: COPD and hypoventilation disorders. Eur Respir Rev 2019;28:190064.  Back to cited text no. 1
Ventura F, Barranco R, Bachetti T, Nozza P, Fulcheri E, Palmieri A, et al. Medico-legal investigation in an explicable case of congenital central hypoventilation syndrome due to a rare variant of the PHOX2B gene. J Forensic Leg Med 2018;58:1-5.  Back to cited text no. 2
Xiaoying L, Lang Y, Liu C, Zhang K. Congenital central hypoventilation syndrome: A report of four cases. Chin J Neonatol 2018;33:262-5.  Back to cited text no. 3
Athayde RA, Oliveira Filho JR, Lorenzi Filho G, Genta PR. Obesity hypoventilation syndrome: A current review. J Bras Pneumol 2018;44:510-8.  Back to cited text no. 4
Masa JF, Pépin JL, Borel JC, Mokhlesi B, Murphy PB, Sánchez-Quiroga MÁ. Obesity hypoventilation syndrome. Eur Respir Rev 2019;28:180097.  Back to cited text no. 5
Elsayed AY, El-Shafey MM, Abdelgawad TT, Ali RA. Predictors of early diagnosis of obesity hypoventilation syndrome among patients with sleep disordered breathing. Egypt J Chest Dis Tuber 2017;66:453-8.  Back to cited text no. 6
Sunwoo BY. Obesity hypoventilation: Pathophysiology, diagnosis, and treatment. Curr Pulmonol Rep 2019;8:31-9.  Back to cited text no. 7
Dhakal S, Maskey R, Bhattarai M. Interlink between obesity hypoventilation syndrome and obstructive sleep apnea. Do we need to screen patients for OHS in obese OSA patients? J Diabetes Endocrinol Assoc Nepal 2020;4:17-20.  Back to cited text no. 8
Sivam S, Poon J, Wong KK, Yee BJ, Piper AJ, D'Rozario AL, et al. Slow-frequency electroencephalography activity during wake and sleep in obesity hypoventilation syndrome. Sleep 2020;43:zsz214.  Back to cited text no. 9
Babak A, Rouzbahani R, Khalili Nejad R, Rafiee Zadeh A. Comparison of nutritional behaviors and physical activities between overweight/obese and normal-weight adults. Adv Biomed Res 2019;8:62.  Back to cited text no. 10
[PUBMED]  [Full text]  
Koutsimani P, Montgomery A, Georganta K. The relationship between burnout, depression, and anxiety: A systematic review and meta-analysis. Front Psychol 2019;10:284.  Back to cited text no. 11
Zhou L, Chen P, Peng Y, Ouyang R. Role of oxidative stress in the neurocognitive dysfunction of obstructive sleep apnea syndrome. Oxid Med Cell Longev 2016;2016:9626831.  Back to cited text no. 12
Vancini RL, Rayes AB, Lira CA, Sarro KJ, Andrade MS. Pilates and aerobic training improve levels of depression, anxiety and quality of life in overweight and obese individuals. Arq Neuropsiquiatr 2017;75:850-7.  Back to cited text no. 13
Nigatu YT, Reijneveld SA, de Jonge P, van Rossum E, Bültmann U. The combined effects of obesity, abdominal obesity and major depression/anxiety on health-related quality of life: The LifeLines Cohort Study. PLoS One 2016;11:e0148871.  Back to cited text no. 14
Kolotkin RL, Andersen JR. A systematic review of reviews: Exploring the relationship between obesity, weight loss and health-related quality of life. Clin Obes 2017;7:273-89.  Back to cited text no. 15
Sivam S, Yee B, Wong K, Wang D, Grunstein R, Piper A. Obesity hypoventilation syndrome: Early detection of nocturnal-only hypercapnia in an obese population. J Clin Sleep Med 2018;14:1477-84.  Back to cited text no. 16
Masa JF, Corral J, Caballero C, Barrot E, Terán-Santos J, Alonso-Álvarez ML, et al. Non-invasive ventilation in obesity hypoventilation syndrome without severe obstructive sleep apnoea. Thorax 2016;71:899-906.  Back to cited text no. 17
van der Leest S, Duiverman ML. High-intensity non-invasive ventilation in stable hypercapnic COPD: Evidence of efficacy and practical advice. Respirology 2019;24:318-28.  Back to cited text no. 18
Sequeira TC, BaHammam AS, Esquinas AM. Noninvasive ventilation in the critically Ill patient with obesity hypoventilation syndrome: A review. J Intensive Care Med 2017;32:421-8.  Back to cited text no. 19
Zadeh AR, Eghbal AF, Mirghazanfari SM, Ghasemzadeh MR, Nassireslami E, Donyavi V. Nigella sativa extract in the treatment of depression and serum Brain-Derived Neurotrophic Factor (BDNF) levels. J Res Med Sci 2022;27:28.  Back to cited text no. 20
Piper AJ, BaHammam AS, Javaheri S. Obesity hypoventilation syndrome: Choosing the appropriate treatment of a heterogeneous disorder. Sleep Med Clin 2017;12:587-96.  Back to cited text no. 21
Soghier I, Brożek JL, Afshar M, Tamae Kakazu M, Wilson KC, Masa JF, et al. Noninvasive ventilation versus CPAP as initial treatment of obesity hypoventilation syndrome. Ann Am Thorac Soc 2019;16:1295-303.  Back to cited text no. 22
Baiamonte P, Gruttad'Auria CI, Mazzuca E, Algeri M, Arena C, Linguanti G, et al. Compliance to ventilatory treatment in a cohort of patients on home CPAP or NIV: Analysis by diagnosis, treatment type, and comorbidities. Eur Respiratory Soc 2019;54:PA4154.  Back to cited text no. 23
Argun Baris S, Tuncel D, Ozerdem C, Kutlu H, Onyilmaz T, Basyigit I, et al. The effect of positive airway pressure therapy on neurocognitive functions, depression and anxiety in obesity hypoventilation syndrome. Multidiscip Respir Med 2016;11:35.  Back to cited text no. 24
Hida W, Okabe S, Tatsumi K, Kimura H, Akasiba T, Chin K, et al. Nasal continuous positive airway pressure improves quality of life in obesity hypoventilation syndrome. Sleep Breath 2003;7:3-12.  Back to cited text no. 25
Bouloukaki I, Mermigkis C, Michelakis S, Moniaki V, Mauroudi E, Tzanakis N, et al. The association between adherence to positive airway pressure therapy and long-term outcomes in patients with obesity hypoventilation syndrome: A prospective observational study. J Clin Sleep Med 2018;14:1539-50.  Back to cited text no. 26